Clinical Profile, Triggers, and Management of Anaphylaxis in a Southeastern Iranian Emergency Department: A 2023 Cross-Sectional Study

Document Type : Original Article

Authors

1 Assistant Professor of Allergy and Clinical Immunology, Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran

2 Assistant Professor of Internal Medicin, School of Medicine Ali Ibn Abitaleb Hospital Zahedan University of Medical Sciences, Zahedan, Iran

3 Medical student, Zahedan University of Medical Sciences, Zahedan, Iran

Abstract
Abstract:
Background: Anaphylaxis is a life-threatening systemic hypersensitivity reaction of increasing global incidence. Regional epidemiological data on triggers and management are essential for improving outcomes. No previous study has investigated this condition in Iran's Sistan and Baluchestan province. This study aimed to characterize the clinical manifestations, causes, and management of anaphylaxis in emergency departments in Zahedan, Iran.
Methods: This cross-sectional study enrolled 78 patients diagnosed with anaphylaxis using standard criteria who presented to Zahedan University of Medical Sciences emergency departments in 2023. Data on demographics, triggers, clinical features, and treatment were collected via checklist and analyzed using SPSS version 26, with p<0.05 considered significant.
Results: Patients' mean age was 26.6±17.6 years, with 52.6% female. Most reactions occurred at home (62.8%). Medications and insect stings were the most common triggers (32.9% each), followed by food (27.3%). Cutaneous (83.3%) and respiratory (78.2%) symptoms predominated. Intravenous fluids (88.5%), antihistamines (85.9%), and steroids (76.9%) were most frequently administered. Epinephrine was used in 65.4% of cases, with recipients being significantly younger than non-recipients (24.6±16.6 vs 31.2±19.1 years, p=0.048). Most patients (42.3%) recovered completely in the emergency department with no fatalities.
Conclusion: Insect stings and medications are the predominant anaphylaxis triggers in this region. The high prevalence of cutaneous and respiratory symptoms requires heightened clinical suspicion. Suboptimal epinephrine use indicates a critical management gap, necessitating improved guideline adherence and enhanced education for healthcare professionals and the public.

Keywords

Subjects

  • Receive Date 23 November 2025
  • Accept Date 28 May 2026